China Shineway Pharmaceutical Group Limited (HKG:2877)
Hong Kong · Delayed Price · Currency is HKD 8.13
-0.18 (-2.11%)
Sep 18, 2026, 4:08 PM HKT
HKG:2877 Revenue
China Shineway Pharmaceutical Group had revenue of 1.48B CNY in the half year ending December 31, 2025, a decrease of -29.99%. This brings the company's revenue in the last twelve months to 2.66B, down -20.34% year-over-year. In the year 2025, China Shineway Pharmaceutical Group had annual revenue of 3.14B, down -17.01%.
Revenue (ttm)
2.66B CNY
Revenue Growth
-20.34%
P/S Ratio
2.00
Revenue / Employee
943.94K CNY
Employees
2,822
Market Cap
6.14B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.14B | -642.62M | -17.01% |
| Dec 31, 2024 | 3.78B | -738.50M | -16.35% |
| Dec 31, 2023 | 4.52B | 565.90M | 14.32% |
| Dec 31, 2022 | 3.95B | 727.09M | 22.56% |
| Dec 31, 2021 | 3.22B | 567.85M | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.